The abstract mentions that antibody discovery has improved understanding of myelitis pathophysiology but focuses on a review of uncommon myelopathies where mechanisms remain poorly characterized. Understanding these mechanisms is critical for developing targeted therapies for rare but debilitating conditions.
Gap type: unexplained_observation
Source paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)
MOG-IgG binds myelin oligodendrocyte glycoprotein on oligodendrocytes, engaging activating Fcγ receptors (FcγRI, FcγRIII) on perivascular/spinal cord macrophages, triggering antibody-dependent cellular phagocytosis and release of pro-inflammatory cytokines. However, the mechanistic exclusivity claim over complement is disputed—complement deposition has been observed in MOGAD lesions (Takeshita et al., 2017), and EAE models may not fully recapitulate human disease. The pathway requires integration of both macrophage-mediated demyelination and complement components rather than binary predominance.
No AI visual card yet
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
6 citations6 with PMIDValidation: 0%3 supporting / 3 opposing
✓For(3)
No supporting evidence
No opposing evidence
(3)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
4
2
MECH 4CLIN 2GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
Macrophage-predominant pathology in MOGAD lesions …
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-21 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Specific Therapeutic and Mechanistic Hypotheses for Uncommon Immune-Mediated Myelopathies
Background Context
The paper (PMID: 34715593) identifies gaps in understanding pathophysiology of uncommon myelopathies including MOG-antibody disease (MOGAD), antibody-negative autoimmune myelopathies, paraneoplastic syndromes, and GFAP astrocytopathy. The review notes that antibody discovery has clarified some cases but mechanisms of tissue injury remain incompletely characterized.
Hypothesis 1: MOGAD Demyelination via FcγR-Mediated Macrophage Engagement
Title: MOG-IgG induces spinal
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Hypothesis 1: MOGAD FcγR-Mediated Demyelination
Weak Links
Overreliance on EAE models: Takai et al. used C57BL/6 EAE—a fundamentally different disease model than human MOGAD, which rarely produces spontaneous relapse in the same pattern
Mechanistic exclusivity: The hypothesis claims this mechanism "predominates over complement," but Peschl et al. describe macrophage-predominant pathology—not that complement is absent. Multiple MOGAD cases show complement deposition (Fischer et al., 2020)
CSF1R/IRAK4 as loose ends: These pathways are included without mechanistic justif
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Hypothesis 1 (MOGAD FcγR-Mediated Demyelination) → CONDITIONAL VIABILITY Confidence 0.58 passes the skeptical threshold given: (1) macrophage-predominant pathology in MOGAD is documented, (2) SYK inhibitors are clinically available, (3) the falsifying experiments are mechanistically tractable. The complement issue requires incorporation rather than dismissal.
Hypothesis 2 (Paraneoplastic CD8+ T Cell Neuronal Injury) → MARGINAL VIABILITY Confidence 0.41 reflects fundamental uncertainties: motor
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
{ "ranked_hypotheses": [ { "title": "MOG-IgG induces spinal cord demyelination through Fcγ receptor-dependent macrophage activation", "description": "MOG-IgG binds myelin oligodendrocyte glycoprotein on oligodendrocytes, engaging activating Fcγ receptors (FcγRI, FcγRIII) on perivascular/spinal cord macrophages, triggering antibody-dependent cellular phagocytosis and release of pro-inflammatory cytokines. However, the mechanistic exclusivity claim over complement is disputed—complement deposition has been observed in MOGAD lesions (Takeshita et al., 2017), and EAE models may n